Harbin Gloria Pharmaceuticals Co., Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 774.21 million compared to CNY 705.23 million a year ago. Revenue was CNY 774.21 million compared to CNY 705.23 million a year ago. Net income was CNY 0.998263 million compared to CNY 21.9 million a year ago. Basic earnings per share from continuing operations was CNY 0.0005 compared to CNY 0.01 a year ago. Diluted earnings per share from continuing operations was CNY 0.0005 compared to CNY 0.01 a year ago.